Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery

Journal of Controlled Release : Official Journal of the Controlled Release Society
Bert DevriendtEric Cox

Abstract

Vaccination is the most efficient way to combat and prevent infectious diseases. However, most vaccines are administered systemically and are ineffective in eliciting protective immunity at mucosal sites. By contrast, oral delivery of therapeutic or prophylactic vaccines induces both systemic and mucosal immune responses. Additionally, oral delivery offers several advantages over systemic vaccination, such as ease of administration and increased safety. Despite these advantages, progress in oral vaccination has been rather slow due to the many hurdles posed by the gastrointestinal tract. To be effective as oral vaccine, antigens need to be resistant against or protected from acidic and enzymatic denaturation before reaching their target site, where their uptake should be enhanced, resulting in an increased immunogenicity. Despite the development of numerous delivery systems, their uptake by the intestinal epithelium remains poor. Most efforts are focussed on strategies to augment M cell mediated uptake. In the current review we discuss the possible strategies to target transcytotic receptors expressed on the apical surface of not only M cells, but also enterocytes to facilitate the uptake of antigen-loaded biodegradable micropa...Continue Reading

References

Jan 12, 1989·Nature·N E Simister, K E Mostov
Jul 1, 1985·European Journal of Immunology·N E Simister, A R Rees
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·W I LencerJ L Madara
Jun 11, 1999·International Journal of Pharmaceutics·B Carreno-GómezA T Florence
Oct 8, 1999·The Journal of Clinical Investigation·B L DickinsonW I Lencer
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·F SierroJ C Sirard
Apr 12, 2002·Veterinary Immunology and Immunopathology·Wim Van den BroeckBruno M Goddeeris
Apr 2, 2003·Nature Reviews. Immunology·Allan McI Mowat
Feb 10, 2004·Molecular Biology of the Cell·Steven M ClaypoolRichard S Blumberg
Feb 19, 2004·Advanced Drug Delivery Reviews·Mark A JepsonBarry H Hirst
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Myoung Ho JangHiroshi Kiyono
Jul 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Raimund J OberE Sally Ward
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·Ilka M Vasconcelos, José Tadeu A Oliveira
Nov 16, 2004·Veterinary Immunology and Immunopathology·Imre Kacskovics
Nov 25, 2004·Advanced Drug Delivery Reviews·Neil Foster, Barry H Hirst
Jan 18, 2005·Science·Jan Hendrik NiessHans-Christian Reinecker
Feb 26, 2005·Infection and Immunity·George HajishengallisTerry D Connell
Mar 23, 2005·Vaccine·Franziska Roth-WalterErika Jensen-Jarolim
Apr 7, 2005·Nature Medicine·Jan Holmgren, Cecil Czerkinsky
May 24, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·F VerdonckE Cox
Sep 27, 2005·Drug Discovery Today·David J BraydenAlan W Baird
Oct 21, 2005·Cellular and Molecular Life Sciences : CMLS·E C Lavelle
Oct 22, 2005·International Journal of Medical Microbiology : IJMM·Chantal Le Bouguénec
Dec 22, 2005·Infection and Immunity·Peter TyrerJennelle M Kyd
Jan 13, 2006·Methods : a Companion to Methods in Enzymology·E C Lavelle
Feb 17, 2006·International Immunology·Imre KacskovicsLennart Hammarström
Oct 20, 2006·Journal of Nanoscience and Nanotechnology·Hesham H SalmanJuan M Irache
Oct 20, 2006·Springer Seminars in Immunopathology·Masaru YoshidaRichard S Blumberg
Nov 2, 2006·Expert Opinion on Drug Delivery·Ed C Lavelle, D T O'Hagan

❮ Previous
Next ❯

Citations

Apr 27, 2013·Comparative Immunology, Microbiology and Infectious Diseases·Christophe CasteleynChris Van Ginneken
Nov 10, 2013·PloS One·Marek FiglerowiczCzeslaw Sadowski
Jan 7, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cong LuoZhonggui He
Mar 5, 2013·Advanced Drug Delivery Reviews·Anne des RieuxVéronique Préat
Oct 16, 2013·Expert Review of Vaccines·Francesca UngaroLuigi Buonaguro
Oct 6, 2012·Expert Opinion on Drug Delivery·Bo Xiao, Didier Merlin
Oct 21, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kim BaertBert Devriendt
Apr 2, 2015·Plant Biotechnology Journal·Yoseph ShaaltielDavid Aviezer
Mar 27, 2016·Pharmacology & Therapeutics·João Pedro MartinsBruno Sarmento
Jan 7, 2015·Veterinary Research·Igor KolotilinRima Menassa
Jul 2, 2014·International Journal of Pharmaceutics·Tongtong MaSiling Wang
Mar 16, 2013·Gut Microbes·Qing Zhu, Jay A Berzofsky
Dec 5, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Bert DevriendtEric Cox
Mar 19, 2014·Drug Discovery Today·Xingwang Zhang, Wei Wu
Jun 14, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Abhijit A DateLaura M Ensign
Oct 31, 2016·Advanced Drug Delivery Reviews·Zeinab HosseinidoustMetin Sitti
Sep 15, 2018·Human Vaccines & Immunotherapeutics·Miguel F Carvalho, Davinder Gill
Dec 14, 2019·Advanced Materials·Shiran FerberNatalie Artzi
Oct 23, 2018·Expert Opinion on Therapeutic Targets·Kelly Van Looveren, Claude Libert
Apr 1, 2013·Journal of Drug Targeting·Jitinder S WilkhuYvonne Perrie
Apr 26, 2017·Advanced Drug Delivery Reviews·Julia E Vela RamirezNicholas A Peppas
Apr 20, 2021·Journal of Biomedical Materials Research. Part a·Xi WuBo Wang
Aug 20, 2021·Advanced Drug Delivery Reviews·Yuandong ZhangXun Sun
Jan 5, 2018·Bioconjugate Chemistry·Stephanie LongetEd C Lavelle
Nov 2, 2021·Frontiers in Immunology·Hans Van der WekenBert Devriendt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

Expert Opinion on Drug Delivery
Bert DevriendtEric Cox
Trends in Immunology
Olga Schulz, Oliver Pabst
Journal of Controlled Release : Official Journal of the Controlled Release Society
Marie GarinotV Préat
© 2022 Meta ULC. All rights reserved